| The Pharmaceutical Journal |
|
News summary |
Updated HRT prescribing adviceHormone replacement therapy should no longer be recommended as first choice therapy for prevention of osteoporosis, according to new advice from the Medicines and Healthcare products Regulatory Agency. Full details are available from the MHRA website (www.mhra.gov.uk). |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site Map | Contact us